APA (7th ed.) Citation

AL-Quraini, M., Rizvi, M., AL-Jabri, Z., Sami, H., AL-Muzahmi, M., AL-Muharrmi, Z., . . . Soman, R. (2022, January). Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant <i>Klebsiella Pneumoniae</i>: Exploring A Colistin Sparing Protocol. Antibiotics.

Chicago Style (17th ed.) Citation

AL-Quraini, Manawr, Meher Rizvi, Zaaima AL-Jabri, Hiba Sami, Muna AL-Muzahmi, Zakariya AL-Muharrmi, Neelam Taneja, Ibrahim AL-Busaidi, and Rajeev Soman. "Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol." Antibiotics Jan. 2022.

MLA (9th ed.) Citation

AL-Quraini, Manawr, et al. "Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol." Antibiotics, Jan. 2022.